Lv3
230 积分 2023-10-07 加入
PCMO L01—Setting Specifications for Biological Investigational Medicinal Products
8天前
已完结
Regulatory Issues
11天前
已完结
Heterogeneity of monoclonal antibodies revealed by charge-sensitive methods
12天前
已完结
Identification of multiple sources of charge heterogeneity in a recombinant antibody
12天前
已完结
Isolation and characterization of therapeutic antibody charge variants using cation exchange displacement chromatography
12天前
已完结
Preclinical and Clinical Development of Biosimilar Antibodies
13天前
已完结
Cell Line and Cell Culture Development for Biosimilar Antibody-Drug Manufacturing
14天前
已完结
Product Analysis of Biosimilar Antibodies
14天前
已完结
Comparative Assessment of the Effect of Hyper-glycosylation on the Pattern and Kinetics of Degradation of Darbepoetin Alfa using a Stability-Indicating Orthogonal Testing Protocol
18天前
已完结
Stability of Monoclonal Antibodies at High-Concentration: Head-to-Head Comparison of the IgG1 and IgG4 Subclass
21天前
已完结
皖公网安备34019202002308
